4-morpholin-4-yl-butyryl chloride | 871905-88-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 4-morpholin-4-yl-butyryl chloride
• 英文别名: N-phenylpropyl-carbamoyl chloride；4-(Morpholin-4-yl)butanoyl chloride；4-morpholin-4-ylbutanoyl chloride
• CAS: 871905-88-3
• 化学式: C₈H₁₄ClNO₂
• 分子量: 191.658
• InChiKey: DXKAHMUXWHCNOT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-[6-(4-hydroxy-phenyl)-hexyl]-heptane-3,5-dione 、 4-morpholin-4-yl-butyryl chloride 以 二氯甲烷 为溶剂， 反应 48.0h， 生成 4-<6-(Hydroxyphenyl)hexyl>-3.5-heptandion-4-morpholinobutanoat
  参考文献：
  名称：

  Antiviral activity of some .beta.-diketones. 1. Aryl alkyl diketones. In vitro activity against both RNA and DNA viruses

  摘要：

  The discovery that 4-[3-ethyl-6-[(3,4-methylenedioxy)phenyl]-3-hexenyl]-3,5-heptanedione (40) exhibited an in vitro inhibitory effect against equine rhinovirus led to a structure--activity study to establish the criteria for optimum activity. Modification of the bridge included removal of the ethyl group and reduction of the double bond. The heptanedione was replaced with hexanedione and pentanedione with a minimal effect. The effect of replacing the heptanedione with beta-keto esters and monoketones was also investigated. Maintaining the hexamethylene bridge and heptanedione, the methylenedioxy group was replaced with various substitutents. In general, most substituents did not adversely affect activity particularly against equine rhinovirus although there was some variation in activity against herpesvirus. Strongly hydrophilic groups significantly reduced activity. Finally, the effect of varying the length of the alkyl bridge was examined in the 4-hydroxyphenyl series, where peak activity was attained with n = 8.

  DOI：

  10.1021/jm00216a003

文献信息

• Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution
  作者：Charles A. Blum、Xiaozhang Zheng、Harry Brielmann、Kevin J. Hodgetts、Rajagopal Bakthavatchalam、Jayaraman Chandrasekhar、James E. Krause、Daniel Cortright、David Matson、Marci Crandall、Chu K. Ngo、Lawrence Fung、Marta Day、Mark Kershaw、Stéphane De Lombaert、Bertrand L. Chenard

  DOI：10.1016/j.bmcl.2008.07.036

  日期：2008.8

  A focused SAR exploration of the lead 4-aminoquinazoline TRPV1 antagonist 2 led to the discovery of compound 18. In rats, compound 18 is readily absorbed following oral dosing and demonstrates excellent in vivo potency and efficacy in an acute inflammatory pain model. (C) 2008 Elsevier Ltd. All rights reserved.
• Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains
  作者：Chen Zhao、Hing L. Sham、Minghua Sun、Vincent S. Stoll、Kent D. Stewart、Shuqun Lin、Hongmei Mo、Sudthida Vasavanonda、Ayda Saldivar、Chang Park、Edith J. McDonald、Kennan C. Marsh、Larry L. Klein、Dale J. Kempf、Daniel W. Norbeck

  DOI：10.1016/j.bmcl.2005.08.093

  日期：2005.12

  As part of our efforts to identify potent HIV-1 protease inhibitors that are active against resistant viral strains, structural modification of the azacyclic urea (I) was undertaken by incorporating acyl groups as P(1)' ligands. The extensive SAR study has yielded a series of N-acyl azacyclic ureas (II), which are highly potent against both wild-type and multiple PI-resistant viral strains.